CLINICAL_TRIALS
withdrawal
· 2021-02-24
Clinical Trial Update: Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders [Phase 3]
Summary
A Phase 3 trial comparing Panax Ginseng+ associations to Ginkgo Biloba for cognitive function disorders was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMS | Conditions: Memory Deficit | Phase 3 | Status: WITHDRAWN